Bain Capital Life Sciences
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$3.1B
Focus Areas
2
Top Stage
Phase 1/2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Tango Therapeutics | $2.8B |
| Foghorn Therapeutics | $293.5M |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Tango Therapeutics | $2.8B |
| Foghorn Therapeutics | $293.5M |